Parker Waichman LLP

Ibuprofen doubles the risk of a heart attack

Ibuprofen Doubles The Risk Of A Heart Attack. The common painkiller Ibuprofen, sold over the counter in supermarkets and pharmacies, doubles the risk of a heart attack in patients who take it at high doses over a long period, a study has found. The drug is one of the most widely used remedies for headaches, period […]

Ibuprofen

Ibuprofen Doubles The Risk Of A Heart Attack. The common painkiller Ibuprofen, sold over the counter in supermarkets and pharmacies, doubles the risk of a heart attack in patients who take it at high doses over a long period, a study has found.

The drug is one of the most widely used remedies for headaches, period pains and discomfort caused by inflammation.

It is used by millions of arthritis sufferers on a daily basis to relieve painful joints.

But researchers warned people yesterday not to remove the drug from household medicine cabinets.

There was no danger for occasional users and the benefits of the drug for patients who depend on it to lead normal lives were still likely to outweigh its risks, they said.

The study is the largest and most definitive of its kind into the effect of non-steroidal anti-inflammatory drugs (NSAIDs) on the heart, involving 138 trials covering 140,000 patients.

It follows concern over a separate group of anti-inflammatories known as the Cox-2 inhibitors which led to the withdrawal of Vioxx in 2004 after it was linked with an increased rate of heart attacks.

Vioxx , made by Merck, is now the subject of a series of multimillion dollar lawsuits from patients who suffered heart attacks which they claim were caused by the drug.

Drug Such As Ibuprofen Increased Risk Of Heart Attacks

Now confirmation that drugs such as Ibuprofen, which the Cox-2 inhibitors were designed to replace, also carry an increased risk of heart attack puts the risks of Vioxx in a different light.

The Coxib drugs have fewer side effects on the gut than the NSAIDs such as Ibuprofen, which are prone to cause gastrointestinal bleeding, and some researchers are questioning whether Vioxx should have been withdrawn.

Scientists from the Clinical Trial Service Unit at the University of Oxford, with colleagues from the University of Rome, carried out the study published in the British Medical Journal.

They combined results from all trials of the two classes of drug in order to provide the most reliable estimate of the increased risk.

Two drugs from among the NSAIDs ibuprofen and the prescription-only diclofenac increased the risk of a heart attack by almost as much as the Coxib drugs, but a third drug, naproxen, did not.

The researchers say most of the patients in the trials did not have pre-existing heart disease and the increased risk was modest, amounting to three extra heart attacks in every 1,000 people taking Ibuprofen or diclofenac every year.

The two drugs had a lesser effect on the stroke rate.

Overall they increased the risk of any vascular event heart attack or stroke by 40 per cent.

Colin Baigent, of the Medical Research Council, who directed the research, said: “That is a relatively low risk for someone who can’t get out of bed in the morning because their body is racked with pain. What we have demonstrated is that both the NSAIDs and the Coxibs have the same kind of risks but it is for doctors to discuss those risks with their patients.”

He added: “For those on smaller doses the supposition must be that the risks are lower. The advice has always been to take the lowest dose for the shortest time necessary to control symptoms. People who are popping these for the odd headache, the risks to them are minimal.”

Dr Baigent said the scare over Vioxx had been overdone.

“There was a worry at the time that this particular drug was to blame and it was withdrawn. Probably all these drugs are associated with some hazard but they control pain very effectively. We have to decide which drug is best for each patient. This debate has been ill informed and a bit hysterical.”

A spokeswoman for Arthritis Care said 9 million people in the UK suffered from arthritis and “millions” were taking high doses of pain killers on a regular basis.

“This is a patient choice issue. All drugs have side effects but patients taking large doses are in a lot of pain. They have to weigh up the possibility of an enjoyable life against something else.”

Reckitt Benckiser, which makes Nurofen a non-prescription ibuprofen-based pain reliever, stressed the BMJ study did not look at their drug, only at higher dose prescription drugs.

Zephanie Jordan, at Reckitt Benckiser, said: “Ibuprofen is a highly effective pain medicine that has been used safely in more than 50 countries worldwide and by millions of people.

“There is a considerable body of scientific evidence illustrating the safety and efficacy of ibuprofen when used at low doses and for short term use.”

Need Legal Help Regarding Ibuprofen?

The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
I would highly recommend Parker Waichman for legal services. As part of the 9/11 Victims Compensation Fund, I had some concerns about the process for applying for an award. This firm and especially Tina Morace made it quite easy. Tina handled all the detail professionally, sensitively and with compassion. I cannot overstate the confidence I had in her and this firm. They made a difficult situation much more comfortable.
Craig Evans
3 years ago
5 Star Reviews 150
Michelle Josama was absolutely fantastic. Glad we got her for our case. Had a great experience!
Rafael Garcia
5 years ago
5 Star Reviews 150
I wanted to thank Ms.Benita Rollis, of Parker Waichman LLC for seeing me through this entire process. Your professionalism in seeing me through this case was exemplary. Ms. Rollis is a 10 in my book. Thank you and regards
Avril Kendall
a year ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038